Zanosar Powder, For Solution
Product Images NDC 68118-500

5 FDA label images from Esteve Pharmaceuticals, S.a. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Zanosar (NDC 68118-500). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Esteve Pharmaceuticals, S.a., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Page 1 (Page 1)

Page 1 (Page 1)
A drug information notice from Esteve Pharmaceuticals dated August 14, 2026, discussing the temporary importation of non-FDA-approved Zanosar (Streptozocin) powder for concentrate for solution for infusion due to a shortage in the U.S. It includes storage instructions and main characteristics, listing the pharmaceutical form as powder for concentrate for solution for infusion and providing related authorization numbers.*
FDA Label Image

Page 2 (Page 2)

Page 2 (Page 2)
Packaging label image for Zanosar 1 g powder for concentrate for solution for infusion containing Streptozocin. The carton and container labels are shown with pink and white color scheme, featuring the ESTEVE Pharmaceuticals branding. The label indicates the product is for intravenous use and is cytotoxic. The carton includes directions for storage, special precautions, and usage warnings.*
FDA Label Image

Page 3 (Page 3)

Page 3 (Page 3)
This text panel provides important information about the imported product, including reconstituted solution storage conditions stating stability for 24 hours below 25°C in a specific sodium chloride solution bag. It addresses barcode registration issues on U.S. scanning systems, serialization compliance, prescription labeling, and instructions for reporting quality problems or adverse events related to the product.*
FDA Label Image

Vial (Label)

Vial (Label)
Label for Zanosar 1 g powder for concentrate for solution for infusion. The active ingredient is Streptozocin. The product is intended for intravenous use and single use only. The label includes the ESTEVE logo and indicates the product is cytotoxic. The label features batch and expiry information area and a barcode.*
FDA Label Image

Carton Label (Box Label)

Carton Label (Box Label)
Packaging label for Zanosar 1 g powder for concentrate for solution for infusion containing Streptozocin. The label indicates it is for UK use only, with 1 vial marked as cytotoxic. Labeler is ESTEVE PHARMACEUTICALS, S.A. Instructions include storage conditions and handling precautions. Barcode and regulatory information are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.